Understand the source comparison
How to Use Peptides for Tennis Elbow: Protocol Comparison
Mechanism Upregulates VEGF and growth hormone receptors; enhances fibroblast migration to injury site Promotes actin polymerisation and angiogenesis; reduces inflammation via downregulation of pro-inflammatory cytokines Complementary pathways. BPC-157 targets
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mechanism
- Upregulates VEGF and growth hormone receptors; enhances fibroblast migration to injury site
- Promotes actin polymerisation and angiogenesis; reduces inflammation via downregulation of pro-inflammatory cytokines
- Complementary pathways. BPC-157 targets collagen synthesis; TB-500 addresses tissue remodelling and vascular support
- Combined protocols in research showed 30–40% faster tendon healing vs monotherapy in animal models
- Typical Research Dose
- 250–500 mcg daily subcutaneous
- 2–5 mg per week subcutaneous (1–2 injections)
- 250 mcg BPC-157 daily + 2.5 mg TB-500 twice weekly
- Dose ranges reflect published trial parameters. Not personal recommendations
- Injection Frequency
- Once daily
- 1–2 times per week
- Daily BPC-157 + biweekly TB-500
- Higher frequency increases user error risk. TB-500's longer half-life reduces administration burden
- Reconstitution Stability
- 28 days refrigerated at 2–8°C
- Both require identical cold storage; discard after 28 days regardless of appearance
- Temperature excursion above 8°C denatures peptides irreversibly
- Cost Per 4-Week Cycle
- Approx. $80–$120 (5 mg vial)
- Approx. $150–$200 (20 mg vial)
- Approx. $230–$320 combined
- Combined therapy costs 2–3× monotherapy but may reduce total recovery time based on rodent trial data